A detailed history of Ra Capital Management, L.P. transactions in Pep Gen Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 10,689,545 shares of PEPG stock, worth $46.2 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares
10,689,545
Previous 10,689,545 -0.0%
Holding current value
$46.2 Million
Previous $171 Million 46.43%
% of portfolio
1.27%
Previous 2.57%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$10.54 - $18.14 $113 Million - $194 Million
10,689,545 New
10,689,545 $171 Million
Q1 2024

May 15, 2024

BUY
$6.63 - $17.3 $17 Million - $44.2 Million
2,557,593 Added 31.45%
10,689,545 $157 Million
Q4 2023

Feb 14, 2024

BUY
$3.86 - $7.96 $31.4 Million - $64.7 Million
8,131,952 New
8,131,952 $55.3 Million
Q2 2022

Aug 15, 2022

BUY
$9.0 - $12.89 $73.2 Million - $105 Million
8,131,952 New
8,131,952 $80.8 Million

Others Institutions Holding PEPG

About PepGen Inc.


  • Ticker PEPG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,631,900
  • Market Cap $102M
  • Description
  • PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...
More about PEPG
Track This Portfolio

Track Ra Capital Management, L.P. Portfolio

Follow Ra Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.